Barely Significant
← all excerpts

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.

Blood Cancer J · 2016 · PMC4742634 · PMID 26745852

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP< 0.001actually significant
The difference between the groups for the distribution of creatinine clearance categories was highly significant ( P< 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.